Uptake of dopamine and 5-hydroxytryptamine by platelets of patients with Parkinsonism.
AUTOR(ES)
Aminoff, M J
RESUMO
The uptake of tritiated dopamine and 5-hydroxytryptamine by platelets from 11 patients with Parkinsonism who were not receiving any medication, and from 11 control subjects matched for sex and for age within a decade was compared. No significant differences were found in the uptake of either amine. Our findings, therefore, provide no support for the belief that there is a generalised defect of dopamine systems in Parkinson's disease.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=493100Documentos Relacionados
- CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
- Effects of reserpine and chlorpromazine on 5-hydroxytryptamine uptake of platelets from migrainous and control subjects
- Loss of 5-hydroxytryptamine from mammalian circulating labelled platelets
- Uptake and release of 14C-5-hydroxytryptamine by platelets in affective illness
- Adenine nucleotides and 5-hydroxytryptamine released by aggregating platelets inhibit adrenergic neurotransmission in canine coronary artery.
